Related references
Note: Only part of the references are listed.RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice
Denuja Karunakaran et al.
CIRCULATION (2021)
Impact of myeloid RIPK1 gene deletion on atherogenesis in ApoE-deficient mice
Isabelle Coornaert et al.
ATHEROSCLEROSIS (2021)
Stage-Dependent Impact of RIPK1 Inhibition on Atherogenesis: Dual Effects on Inflammation and Foam Cell Dynamics
Yuze Zhang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Cell-specific and athero-protective roles for RIPK3 in a murine model of atherosclerosis
Sarah Colijn et al.
DISEASE MODELS & MECHANISMS (2020)
Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease
R. K. Subbarao Malireddi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events
Tom Delanghe et al.
TRENDS IN CELL BIOLOGY (2020)
TRADD Mediates RIPK1-Independent Necroptosis Induced by Tumor Necrosis Factor
Lili Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Loss of MLKL (Mixed Lineage Kinase Domain-Like Protein) Decreases Necrotic Core but Increases Macrophage Lipid Accumulation in Atherosclerosis
Adil Rasheed et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Lauren Mifflin et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation
Yves Dondelinger et al.
NATURE COMMUNICATIONS (2019)
Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis
Kim Newton et al.
NATURE (2019)
Everolimus depletes plaque macrophages, abolishes intraplaque neovascularization and improves survival in mice with advanced atherosclerosis
Ammar Kurdi et al.
VASCULAR PHARMACOLOGY (2019)
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Wei Wang et al.
CANCER CELL (2018)
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
Philip A. Harris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis
Kelby W. Wegner et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Sex differences in the LDL receptor knockout mouse model of atherosclerosis
Neel A. Mansukhani et al.
ARTERY RESEARCH (2017)
RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4
Malek Najjar et al.
IMMUNITY (2016)
Holding RIPK1 on the Ubiquitin Leash in TNFR1 Signaling
Nieves Peltzer et al.
TRENDS IN CELL BIOLOGY (2016)
Cholesterol-independent effects of atorvastatin prevent cardiovascular morbidity and mortality in a mouse model of atherosclerotic plaque rupture
Lynn Roth et al.
VASCULAR PHARMACOLOGY (2016)
Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis
Denuja Karunakaran et al.
SCIENCE ADVANCES (2016)
NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling
Yves Dondelinger et al.
MOLECULAR CELL (2015)
RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality
Lingjun Meng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Elastin fragmentation inatheroscleroticmice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death
Carole Van der Donckt et al.
EUROPEAN HEART JOURNAL (2015)
Non-invasive assessment of pulse wave velocity in mice by means of ultrasound images
Nicole Di Lascio et al.
ATHEROSCLEROSIS (2014)
Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
Zhenyu Cai et al.
NATURE CELL BIOLOGY (2014)
MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates
Yves Dondelinger et al.
CELL REPORTS (2014)
A Role of RIP3-Mediated Macrophage Necrosis in Atherosclerosis Development
Juan Lin et al.
CELL REPORTS (2013)
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Liming Sun et al.
CELL (2012)
Necrotic cell death in atherosclerosis
Wim Martinet et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Computational Stress Analysis of Atherosclerotic Plaques in ApoE Knockout Mice
Yuliya Vengrenyuk et al.
ANNALS OF BIOMEDICAL ENGINEERING (2010)
Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
YoungSik Cho et al.
CELL (2009)
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
Sudan He et al.
CELL (2009)
Impaired Fibrillin-1 Function Promotes Features of Plaque Instability in Apolipoprotein E-Deficient Mice
Jozef L. Van Herck et al.
CIRCULATION (2009)
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Duan-Wu Zhang et al.
SCIENCE (2009)
TNF-α induces two distinct caspase-8 activation pathways
Lai Wang et al.
CELL (2008)
Pathology of the vulnerable plaque
R Virmani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis - The importance of lesion stage and phagocytic efficiency
I Tabas
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis
DM Schrijvers et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)